The Centers for Disease Control and Prevention and Food and Drug Administration have identified seven linked cases of sepsis after transfusion from bacterially contaminated platelet blood products since 2018, according to a recent FDA safety communication.  
 
“These unusual cases demonstrate that it is important for blood establishments and transfusion services to continue to recognize the risk of bacterial contamination of platelets, including in bacterially tested and pathogen-reduced platelet components,” FDA said.

Related News Articles

Headline
Speakers interested in leading conversations and collaborations at the AHA’s new Healthier Together Conference are advised to submit a content proposal by Sept…
Blog
In this insightful conversation hosted by Nancy Myers of the American Hospital Association, we explore how Owensboro Health (Ky.) and CredibleMind are…
Headline
The AHA will accept applications through Oct. 14 for the 2026 AHA Dick Davidson NOVA Award. This award recognizes hospitals and health systems that demonstrate…
Headline
The AHA July 16 announced five winners of the 2025 AHA Dick Davidson NOVA Award for their hospital-led collaborative efforts to improve community…
Headline
The Centers for Medicare & Medicaid Services June 27 announced the rollout of a 6-year technology-enabled prior authorization program pilot. Through…
Headline
AHA podcast: Food as Medicine — How Cleveland Clinic Is Nourishing Community HealthVickie Johnson, executive vice president and chief community officer at…